CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 19 enrolled
Drug / intervention
Exercisebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03280836
NCT03280836N/ACompleted

Women In Steady Exercise Research - Neoadjuvant Exercise Trial

Milton S. Hershey Medical Center·interventional·Posted Sep 13, 2017·Updated Dec 5, 2023

In Brief

A clinical study evaluating Exercise for Breast Neoplasm and Physical Activity. Completed, enrolled 19 participants across 2 sites.

Detailed Summary

The investigators seek to conduct a home based exercise intervention in breast cancer patients whom elect to undergo neoadjuvant chemotherapy. The primary aim of the study is to determine whether breast cancer patients can be enrolled, randomized, retained, and comply with exercise program; and, the feasibility of acquiring, managing and analyzing clinical data.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsNRG Oncology

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedSep 13, 2017
Enrollment StartAug 3, 2017
Primary CompletionDec 21, 2020
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 8.8 years ago

Interventions

Exercisebehavioral

All participants randomized to the intervention group will be asked to keep an exercise log with the date, time, average heart rate obtained from a heart rate monitor, duration of workout and stretching, and any comments regarding the workout. Participants will be instructed to bring workout logs to infusion sessions for review. Participants will also wear a Polar Heart Rate monitor (US model RS400, Polar Electro Inc., Lake Success, NY) during exercise to monitor exercise intensity. The aerobic exercise intervention will work toward the target of 75 minutes physical activity per week at 60%-85% of baseline VO2max.